Kana Mizuno

1.5k total citations
45 papers, 1.0k citations indexed

About

Kana Mizuno is a scholar working on Immunology, Physiology and Molecular Biology. According to data from OpenAlex, Kana Mizuno has authored 45 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 14 papers in Physiology and 10 papers in Molecular Biology. Recurrent topics in Kana Mizuno's work include Sarcoidosis and Beryllium Toxicity Research (12 papers), Complement system in diseases (10 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Kana Mizuno is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (12 papers), Complement system in diseases (10 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Kana Mizuno collaborates with scholars based in Japan, United States and Vietnam. Kana Mizuno's co-authors include Hiroyuki Okamoto, Takeshi Horio, Stella M. Davies, Sonata Jodele, Benjamin L. Laskin, Alexander A. Vinks, Tsuyoshi Fukuda, Christopher E. Dandoy, Jens Goebel and Bradley P. Dixon and has published in prestigious journals such as Blood, European Respiratory Journal and Journal of Investigative Dermatology.

In The Last Decade

Kana Mizuno

43 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kana Mizuno Japan	18	558	236	208	208	169	45	1.0k
Bradley P. Dixon United States	18	783 1.4×	350 1.5×	493 2.4×	205 1.0×	345 2.0×	55	1.4k
Masayoshi Miura Japan	17	473 0.8×	160 0.7×	109 0.5×	54 0.3×	129 0.8×	74	1.1k
Jennifer L. McRae Australia	18	598 1.1×	78 0.3×	280 1.3×	46 0.2×	183 1.1×	27	983
Lucile E. Wrenshall United States	22	367 0.7×	407 1.7×	83 0.4×	75 0.4×	122 0.7×	53	1.5k
Michael Burg Netherlands	19	246 0.4×	208 0.9×	415 2.0×	73 0.4×	99 0.6×	62	1.5k
Julian R. Pratt United Kingdom	16	894 1.6×	451 1.9×	327 1.6×	55 0.3×	142 0.8×	23	1.5k
Dawn R. Wagenknecht United States	20	279 0.5×	57 0.2×	131 0.6×	77 0.4×	345 2.0×	44	956
E. Kondeatis United Kingdom	14	471 0.8×	86 0.4×	45 0.2×	48 0.2×	107 0.6×	22	974
J.P. Duong Van Huyen France	20	273 0.5×	807 3.4×	253 1.2×	75 0.4×	79 0.5×	33	1.7k

Countries citing papers authored by Kana Mizuno

Since Specialization

Citations

This map shows the geographic impact of Kana Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kana Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kana Mizuno more than expected).

Fields of papers citing papers by Kana Mizuno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kana Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kana Mizuno. The network helps show where Kana Mizuno may publish in the future.

Co-authorship network of co-authors of Kana Mizuno

This figure shows the co-authorship network connecting the top 25 collaborators of Kana Mizuno. A scholar is included among the top collaborators of Kana Mizuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kana Mizuno. Kana Mizuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mizuno, Kana, Ashley Teusink‐Cross, Anthony Sabulski, Stella M. Davies, & Sonata Jodele. (2025). Unraveling the Challenges of Non-Responders to the Eculizumab Treatment with High-Risk Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA). Transplantation and Cellular Therapy. 31(2). S542–S543. 1 indexed citations

Kawato, Yasuhiko, Kana Mizuno, Yoshitake Takada, et al.. (2024). Risk assessment of wild fish as environmental sources of red sea bream iridovirus (RSIV) outbreaks in aquaculture. Diseases of Aquatic Organisms. 158. 65–74. 2 indexed citations

Mizuno, Kana, Edmund V. Capparelli, Tsuyoshi Fukuda, et al.. (2023). Model‐Informed Precision Dosing Guidance of Ethosuximide Developed from a Randomized Controlled Clinical Trial of Childhood Absence Epilepsy. Clinical Pharmacology & Therapeutics. 114(2). 459–469. 2 indexed citations

Jodele, Sonata, Christopher E. Dandoy, Paibel Aguayo‐Hiraldo, et al.. (2023). A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation–associated TMA. Blood. 143(12). 1112–1123. 22 indexed citations

Chandra, Sharat, Kana Mizuno, Junfang Zhao, et al.. (2021). Test‐dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non‐malignant disorders. British Journal of Clinical Pharmacology. 88(1). 115–127. 6 indexed citations

Jodele, Sonata, Christopher E. Dandoy, Adam Lane, et al.. (2020). Complement blockade for TA-TMA: lessons learned from large pediatric cohort treated with eculizumab. Blood. 135(13). 1049–1057. 145 indexed citations

Kambe, Naotomo, et al.. (2018). TARC expression in the circulation and cutaneous granulomas correlates with disease severity and indicates Th2-mediated progression in patients with sarcoidosis. Allergology International. 67(4). 487–495. 25 indexed citations

Mizuno, Kana, et al.. (2017). Annular lesions of cutaneous sarcoidosis with granulomatous vasculitis. Journal of Cutaneous Pathology. 44(5). 494–496. 12 indexed citations

Jodele, Sonata, Tsuyoshi Fukuda, Kana Mizuno, et al.. (2015). Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(2). 307–315. 107 indexed citations

10.

Jodele, Sonata, Benjamin L. Laskin, Tsuyoshi Fukuda, et al.. (2015). Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA). Biology of Blood and Marrow Transplantation. 21(2). S225–S226. 2 indexed citations

11.

Mizuno, Kana, Takahiro Hamada, Takashi Hashimoto, & Hiroyuki Okamoto. (2014). Successful treatment with narrow-band UVB therapy for a case of generalized Hailey-Hailey disease with a novel splice-site mutation inATP2C1gene. Dermatologic Therapy. 27(4). 233–235. 8 indexed citations

12.

Jodele, Sonata, Tsuyoshi Fukuda, Alexander A. Vinks, et al.. (2013). Eculizumab Therapy in Children with Severe Hematopoietic Stem Cell Transplantation–Associated Thrombotic Microangiopathy. Biology of Blood and Marrow Transplantation. 20(4). 518–525. 169 indexed citations

13.

Okamoto, Hiroyuki, Kana Mizuno, & Takeshi Horio. (2004). Human Monocyte-derived Multinucleated Giant Cells. PubMed. 73(3). 245–251. 2 indexed citations

14.

Mizuno, Kana, Hiroyuki Okamoto, & T. Horio. (2001). Heightened ability of monocytes from sarcoidosis patients to form multi-nucleated giant cellsin vitroby supernatants of concanavalin A-stimulated mononuclear cells. Clinical & Experimental Immunology. 126(1). 151–156. 34 indexed citations

15.

Mizuno, Kana, Hiroyuki Okamoto, & Takeshi Horio. (2000). Inhibitory influences of tranilast on multinucleated giant cell formation from monocytes by supernatant of concanavalin A-stimulated mononuclear cells. Journal of Dermatological Science. 24(3). 166–170. 14 indexed citations

16.

Okamoto, Hiroyuki, et al.. (1999). Evaluation of Apoptotic Cells Induced by Ultraviolet Light B Radiation in Epidermal Sheets Stained by the TUNEL Technique. Journal of Investigative Dermatology. 113(5). 802–807. 36 indexed citations

17.

Kobayashi, Kenichiro, Tsuyoshi Imai, Shun Adachi, et al.. (1998). Juvenile xanthogranuloma with hematologic changes in dizygotic twins: report of two newborn infants [see comments]. Pediatric Dermatology. 15(3). 203–206. 10 indexed citations

18.

Mizuno, Kana, Hiroyuki Okamoto, & S. Imamura. (1995). Postirradiation multiple minute digitate hyperkeratoses. Clinical and Experimental Dermatology. 20(5). 425–427. 7 indexed citations

19.

Okamoto, Hiroyuki, Kana Mizuno, S. Imamura, Shuntaro Nagai, & Takashi Izumi. (1994). Erythema nodosum-like eruption in sarcoidosis. Clinical and Experimental Dermatology. 19(6). 507–510. 10 indexed citations

20.

Sone, S, E Orino, Kana Mizuno, et al.. (1994). Production of IL-1 and its receptor antagonist is regulated differently by IFN-gamma and IL-4 in human monocytes and alveolar macrophages. European Respiratory Journal. 7(4). 657–663. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact